Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: results from a phase II study by the Nordic Lymphoma Group

Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: results from a phase II study by the Nordic Lymphoma Group

Item
http://www.wikidata.org/entity/Q35236072
First-line treatment and outcome of elderly patients with primary central nervous system lymphoma (PCNSL)--a systematic review and individual patient data meta-analysis.High-dose methotrexate plus temozolomide as a salvage treatment in metastatic central nervous system Lymphoma: two cases report and review of literatureHigh-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study).Population-based experience on primary central nervous system lymphoma 2000-2012: the incidence is increasing.Increasing incidence of primary central nervous system lymphoma but no improvement in survival in Sweden 2000-2013.Evaluation of Memorial Sloan-Kettering Cancer Center and International Extranodal Lymphoma Study Group prognostic scoring systems to predict Overall Survival in intracranial Primary CNS lymphoma.The Diagnosis and Treatment of Primary CNS Lymphoma
P2860

Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: results from a phase II study by the Nordic Lymphoma Group

Item
http://www.wikidata.org/entity/Q35236072
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Successful change of treatment ...... y by the Nordic Lymphoma Group
@ast
Successful change of treatment ...... y by the Nordic Lymphoma Group
@en
type
label
Successful change of treatment ...... y by the Nordic Lymphoma Group
@ast
Successful change of treatment ...... y by the Nordic Lymphoma Group
@en
prefLabel
Successful change of treatment ...... y by the Nordic Lymphoma Group
@ast
Successful change of treatment ...... y by the Nordic Lymphoma Group
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Successful change of treatment ...... y by the Nordic Lymphoma Group
@en
P2093
P2860
P304
P31
P356
10.3324/HAEMATOL.2014.108472
P433
P478
P50
P577
P5875
P698
P932